Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet regimen for treating HIV infection. This medication integrates three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the HIV's ability to multiply within the body, considerably decreasing the viral quantity.